Skip to content

USCB Financial Holdings, Inc. USCB Short-Term Investments

Short-Term Investments at other companies

Unifirst logo
UnifirstUNF
$5.66M-35.7%
CorMedix logo
CorMedixCRMD
$0-100%
Alignment Healthcare logo
Alignment HealthcareALHC
$20.71M-37.9%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$483.59M+91.1%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$49.56M-0.6%
IPG Photonics logo
IPG PhotonicsIPGP
$332.14M-41.1%

Other financials

Income statement

See full
Revenue$26.2M+14.7%
Net income$9.4M+22.1%
EPS (diluted)$0.51+34.2%

Balance sheet

See full
Cash & equivalents$79.0M-19.4%
Total debt$4.8M-38.3%
Total equity$223.2M-0.8%
Total assets$2.8B+6.3%

Cash flow

See full
Operating cash flow$15.3M+4.4%
CapEx$320.0K+596%
Free cash flow$15.0M+2.6%

Valuation

See full
Market cap$363.27M+13.5%
Enterprise value$289.06M+25.8%
P/E13.1×+1.5×
P/S3.9×+0.2×

Profitability

See full
Net margin29.7%-1.8pp
FCF margin55.3%

Returns & leverage

See full
Return on equity12.4%-0.8pp
Debt / equity0.0×

Where this comes from

Reported directly by USCB Financial Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CertificatesOfDepositAtCarryingValue.

The official record: USCB Financial Holdings, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about USCB Financial Holdings, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USCB Financial Holdings, Inc.'s short-term investments?
USCB Financial Holdings, Inc. (USCB) reported short-term investments of $256.8M in Q4 2025.
How has USCB Financial Holdings, Inc.'s short-term investments changed year-over-year?
USCB Financial Holdings, Inc.'s short-term investments increased by 93.1% year-over-year, from $133M to $256.8M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.